the flipside to this watershed announcement was that it represented Biomira electing NOT to take up worldwide rights to CVac . . . . which they were entitled to . . .. . . but would have required that they fund the Phase III trial, and pay PRR a market rate royalty (presumably high single figures).
lol lol lol lol lol lol lol lol lol lol lol lol lol lol lol lol
the flipside to this watershed announcement was that it...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.3¢ |
Change
0.028(7.53%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.3¢ | 36.8¢ | $1.006M | 2.633M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 28285 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 353568 | 14 |
View Market Depth
| Last trade - 13.48pm 30/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |